查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1728331

辛伐他汀市场－全球产业规模、份额、趋势、机会和预测，按销售管道、最终用途、地区和竞争细分，2020-2030 年

Simvastatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球辛伐他汀市场价值为 1.4693 亿美元，预计到 2030 年将达到 2.2687 亿美元，预测期内复合年增长率为 6.51%。辛伐他汀是他汀类降胆固醇药物，广泛用于治疗高胆固醇血症和预防心血管併发症。公众对预防性医疗保健和胆固醇控制的日益关注，推动了成熟市场和新兴市场对其的需求。肥胖、糖尿病和高血压等生活方式相关疾病的盛行率不断上升，这为市场带来了益处，这些疾病会增加心血管风险，促使人们儘早接受他汀类药物治疗。在现有的治疗方法中，辛伐他汀仍然是一种成熟且具有成本效益的选择。低收入国家医疗服务的普及和仿製药价格的提高正在支持市场扩张。然而，该行业也面临来自替代降血脂疗法的竞争、长期使用他汀类药物的安全性问题以及可能影响製造商定价和利润率的监管限制。

市场概览
预测期 2026-2030
2024年市场规模 1.4693亿美元
2030年市场规模 2.2687亿美元
2025-2030 年复合年增长率 6.51%
成长最快的领域 直接的
最大的市场 亚太地区

关键市场驱动因素

製药业的成长

主要市场挑战

安全性问题和副作用

主要市场趋势

增加政府医疗支出

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19 对全球辛伐他汀市场的影响

第五章：全球辛伐他汀市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按销售管道（直接、间接）
    • 依最终用途（高血脂、冠心病、糖尿病相关血脂异常、中风、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美辛伐他汀市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章：欧洲辛伐他汀市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区辛伐他汀市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美辛伐他汀市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲辛伐他汀市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如有）
  • 最新动态

第 13 章：全球辛伐他汀市场：SWOT 分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • ASolution Pharmaceuticals Pvt. Ltd
  • Cipla Ltd
  • Cadila Healthcare Limited
  • Jsons Laboratories
  • SHIVA LIFE SCIENCE PVT LTD
  • Kaizen Pharmachem
  • Rajem Pharmascience Pvt Ltd
  • Jubilant Generics Limited
  • Chemneal Pharmaceuticals LLP
  • Sun Pharmaceutical Industries Limited

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 29085

The Global Simvastatin Market was valued at USD 146.93 million in 2024 and is projected to reach USD 226.87 million by 2030, growing at a CAGR of 6.51% during the forecast period. Simvastatin, a cholesterol-lowering drug in the statin class, is extensively used for managing hypercholesterolemia and preventing cardiovascular complications. Increasing public focus on preventive healthcare and cholesterol control is fueling its demand across both mature and emerging markets. The market benefits from the rising prevalence of lifestyle-related disorders such as obesity, diabetes, and hypertension-conditions that heighten cardiovascular risks and prompt early statin therapy. Simvastatin remains a well-established and cost-effective option among available treatments. Broader access to healthcare services and greater affordability of generic drugs in lower-income nations are supporting market expansion. However, the industry also contends with competition from alternative lipid-lowering therapies, safety-related concerns regarding long-term statin use, and regulatory constraints that may impact pricing and profit margins for manufacturers.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 146.93 Million
Market Size 2030USD 226.87 Million
CAGR 2025-20306.51%
Fastest Growing SegmentDirect
Largest MarketAsia Pacific

Key Market Drivers

Growth in Pharmaceutical Industry

The expansion of the global pharmaceutical industry is a major driver propelling simvastatin demand. With the pharmaceutical sector generating over USD 1.6 trillion in revenue by 2023, its scale is now comparable to the GDP of entire nations. This growth reflects a heightened industry focus on chronic disease management, including cardiovascular conditions-a key area where statins like simvastatin play a central role. As companies increase investments in accessible, cost-effective therapies, the use of generic statins continues to rise globally. Simvastatin, due to its proven efficacy and affordability, remains a staple treatment, particularly in managing long-term cardiovascular risk in both primary and secondary prevention cases.

Key Market Challenges

Safety Concerns and Side Effects

Safety concerns related to simvastatin pose a significant challenge to its continued uptake. Although effective in managing cholesterol levels and lowering cardiovascular risk, simvastatin has been associated with muscle-related side effects, ranging from mild discomfort to serious conditions such as myopathy and rhabdomyolysis. These risks, especially with prolonged use or when combined with interacting drugs like antifungals or immunosuppressants, have led to increased caution among healthcare providers and patients. Regulatory bodies continue to evaluate the risk-benefit profile of simvastatin, and some patients may avoid or discontinue therapy due to perceived or actual adverse effects. These safety issues can impact treatment adherence and overall market performance.

Key Market Trends

Increasing Government Healthcare Spending

Rising government expenditure on healthcare is a key trend supporting simvastatin market growth. In 2023, the U.S. reported healthcare spending of USD 13,432 per capita-well above the average of USD 7,393 among other high-income countries. Similar trends are emerging globally as nations prioritize public health infrastructure and chronic disease prevention. Simvastatin, frequently included on essential medicine lists, benefits from government-led programs that subsidize or reimburse treatments for hyperlipidemia and cardiovascular disease. By supporting early intervention and preventative care through expanded access to medicines, increased public spending plays a crucial role in boosting simvastatin usage, particularly in regions implementing large-scale cardiovascular disease mitigation strategies.

Key Market Players

  • ASolution Pharmaceuticals Pvt. Ltd
  • Cipla Ltd
  • Cadila Healthcare Limited
  • Jsons Laboratories
  • SHIVA LIFE SCIENCE PVT LTD
  • Kaizen Pharmachem
  • Rajem Pharmascience Pvt Ltd
  • Jubilant Generics Limited
  • Chemneal Pharmaceuticals LLP
  • Sun Pharmaceutical Industries Limited

Report Scope:

In this report, the Global Simvastatin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Simvastatin Market, By Sales Channel:

  • Direct
  • Indirect

Simvastatin Market, By End Use:

  • Hyperlipidemia
  • Coronary Heart Disease
  • Diabetes-Related Dyslipidemia
  • Stroke
  • Others

Simvastatin Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Simvastatin Market.

Available Customizations:

Global Simvastatin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Simvastatin Market

5. Global Simvastatin Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Hyperlipidemia, Coronary Heart Disease, Diabetes-Related Dyslipidemia, Stroke, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Simvastatin Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Simvastatin Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Simvastatin Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Simvastatin Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Simvastatin Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Simvastatin Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Simvastatin Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Simvastatin Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Simvastatin Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Simvastatin Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Simvastatin Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Simvastatin Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Simvastatin Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Simvastatin Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Simvastatin Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Simvastatin Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Simvastatin Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Simvastatin Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Simvastatin Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Simvastatin Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Simvastatin Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Simvastatin Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Simvastatin Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Simvastatin Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Simvastatin Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ASolution Pharmaceuticals Pvt. Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Cipla Ltd
  • 15.3. Cadila Healthcare Limited
  • 15.4. Jsons Laboratories
  • 15.5. SHIVA LIFE SCIENCE PVT LTD
  • 15.6. Kaizen Pharmachem
  • 15.7. Rajem Pharmascience Pvt Ltd
  • 15.8. Jubilant Generics Limited
  • 15.9. Chemneal Pharmaceuticals LLP
  • 15.10. Sun Pharmaceutical Industries Limited

16. Strategic Recommendations

17. About Us & Disclaimer